Active + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Chikungunya
Conditions
Chikungunya
Trial Timeline
Jan 31, 2022 → Feb 15, 2024
NCT ID
NCT04650399About Active + Placebo
Active + Placebo is a phase 3 stage product being developed by Valneva SE for Chikungunya. The current trial status is completed. This product is registered under clinical trial identifier NCT04650399. Target conditions include Chikungunya.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04650399 | Phase 3 | Completed |
Competing Products
20 competing products in Chikungunya